The present invention provides a crystal of 2[4-(2,2-dimethylpropoxy)-3-(1H-1,2,3,4-tetrazole-1-yl)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid, said crystal being useful as a therapeutic agent or a prophylactic agent for gout, hyperuricemia, and the like.